Delcath Systems, Inc. (DCTH) News
Follow Delcath Systems, Inc. (DCTH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Delcath Systems Q3 Revenue Beats on Hepzato Growth
EQUITY | Nov 09, 2026, 01:15 PM UTC
M
Delcath Systems Q3 Revenue USD 35.102 Million; Net Income USD 6.952 Million
Reuters reports Q3 revenue of USD 35.102 million versus an IBES estimate of USD 26 million, and net income of USD 6.952 million.
EQUITY | Nov 09, 2026, 01:03 PM UTC
H
Delcath Systems Q2 2026 Earnings Call Transcript
Delcath Systems (NASDAQ: DCTH ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings cal
LIVE | Oct 06, 2026, 09:31 AM UTC
L
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule
Delcath Systems Inc NASDAQ:DCTH
NEWS | Sep 11, 2026, 08:16 PM UTC
L
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awa
NEWS | Sep 11, 2026, 08:01 PM UTC
L
Delcath Systems to Participate in Upcoming Investor Conferences
Delcath Systems to Participate in Upcoming Investor Conferences
EQUITY | Aug 31, 2026, 08:01 PM UTC